rs745693690
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM3PP4
This summary comes from the ClinGen Evidence Repository: The c.13217T>C variant in USH2A is a missense variant predicted to cause substitution of leucine by proline at amino acid 4406 (p.Leu4406Pro). The highest population minor allele frequency in gnomAD v4.1.0 is 0.02% (15/74934) in the African / African American population (PM2_supporting, BS1, and BA1 not met). The computational predictor REVEL gives a score of 0.338, which is neither above nor below the thresholds predicting a damaging or benign impact on USH2A function. This variant has been identified in one individual with Usher syndrome who was compound heterozygous with a pathogenic variant phase unknown (PP4, 0.5 point PM3; PMID:36011402). This individual also had a third variant that was reviewed by the Hearing Loss VCEP and was determined to be likely benign. This variant was also identified in an individual with retinitis pigmentosa who was compound heterozygous with a pathogenic variant, though phase was unknown (0.5 point PM3, PMID:37217489). The variant was also reported in other individuals with Usher syndrome; however, these individuals were not awarded any evidence as zygosity / phasing was unknown, the second variant was likely benign, or the individual had a possible alternate explanation for disease (PMID:26927203, 24944099, 36011402). In summary, this variant has been classified as a variant of uncertain significance for autosomal recessive Usher syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen Hearing Loss VCEP: PM3, PP4 (ClinGen Hearing Loss VCEP specifications version 2; 11.20.2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA1393328/MONDO:0019501/005
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Publications
- Usher syndrome type 2AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Usher syndrome type 2Inheritance: Unknown, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- retinitis pigmentosa 39Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_206933.4. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 250910 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461868Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727232 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74328 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at